UCSF School of Pharmacy leads in NIH funding for 34th year in a row

For the 34th consecutive year, the UCSF School of Pharmacy has received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

School researchers were awarded $29.2 million during the 2013 NIH fiscal year, from October 1, 2012 to September 30, 2013.

“Thirty-plus years of top NIH funding is an accomplishment to celebrate,” said School of Pharmacy Dean B. Joseph Guglielmo, PharmD. “Yet while we look back with pride, we also look forward to an even brighter future.

“This year marked the fourth in a row in which our junior faculty members received the highly selective NIH Director’s New Innovator Award,” noted Guglielmo. “This prestigious award provides millions of dollars for ‘exceptionally innovative’ research. This year’s awardee was Zev Gartner, PhD, the developer of a revolutionary technology toward the construction of complex 3-D human tissues and associated study of biology and therapeutics.”


UCSF Schools Leads the Nation in NIH Biomedical Research Funds

About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.